Surrogates of surrogates: The story of hypertension and 24 h blood pressure monitoring

Canadian Journal of Cardiology

Volumn 21, Issue 8, 2005, Pages 639-642

  Grewal, Jasmine ^a   Lonn, Eva ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Blood pressure; Cardiovascular risks; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; OUTCOMES RESEARCH; PATIENT CARE; REVIEW; RISK ASSESSMENT; SYMPTOMATOLOGY; WHITE COAT HYPERTENSION;

BLOOD PRESSURE MONITORING, AMBULATORY; CANADA; DECISION TREES; HUMANS; HYPERTENSION; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE GUIDELINES;

EID: 22744432341     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. (Erratum in 2003;361:1060)
2. Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35.
3. Myers MG, Haynes RB, Rabkin SW. Canadian hypertension society guidelines for ambulatory blood pressure monitoring. Am J Hypertens 1999;12:1149-57. (Erratum in 2000;13:219)
4. Palatini P, Mormino P, Canali C, et al. Factors affecting ambulatory blood pressure reproducibility. Results of the HARVEST trial. Hypertension 1994;23:211-6.
5. Asagami T, Kushiro T, Inoue J, Kanmatsuse K. Long-term reproducibility and usefulness of daytime recording of noninvasive 24-hour ambulatory blood pressure monitoring in borderline hypertension: A two-year follow-up study. Clin Exp Hypertens 1996;18:637-57.
6. Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Van Hoof R, Amery AK. Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol 1991;67:723-7.
7. Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: A pilot study in Ohasama. J Hypertens 1997;15:357-64.
8. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801. (Erratum in 1995;25:462)
9. Mancia G, Parati G, Hennig M, et al; ELSA Investigators. Relation between blood pressure variability and carotid artery damage in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001;19:1981-9.
10. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999;282:539-46.
11. Clement DL, De Buyzere ML, De Bacquer DA, et al; Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003;348:2407-15.
12. Fagard R, Staessen J, Thijs L, Amery A. Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring. A metaanalysis of comparative studies. Am J Hypertens 1995;8:533-40. (Erratum in 1995;8:1146)
13. Palatini P, Graniero GR, Mormino P, et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study). Am J Hypertens 1996;9:334-41.
14. Mancia G, Zanchetti A, Agabiti-Rosei E, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997;95:1464-70. (Erratum in 1997;96:1065)
15. Palatini P, Mormino P, Santonastaso M, et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: Results from the HARVEST study. Hypertension 1998;31:57-63.
16. Hemmalgarn BR, Zarnke KB, Campbell NRC, et al; Canadian Hypertension Education Program, Evidence-Based Recommendations Task Force. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2004;20:31-40.